Registro:

Referencias:

• Coulie, P.G., Van den Eynde, B.J., van der Bruggen, P., Boon, T., Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy (2014) Nat Rev Cancer, 14 (2), pp. 135-146
• Baitsch, L., Fuertes-Marraco, S.A., Legat, A., Meyer, C., Speiser, D.E., The three main stumbling blocks for anticancer T cells (2012) Trends Immunol, 33 (7), pp. 364-372
• Crespo, J., Sun, H., Welling, T.H., Tian, Z., Zou, W., T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment (2013) Curr Opin Immunol, 25 (2), pp. 214-221
• Coulie, P.G., Brichard, V., Van Pel, A., Wolfel, T., Schneider, J., Traversari, C., A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas (1994) J Exp Med, 180 (1), pp. 35-42
• Parmiani, G., De Filippo, A., Novellino, L., Castelli, C., Unique human tumor antigens: immunobiology and use in clinical trials (2007) J Immunol, 178 (4), pp. 1975-1979
• Palucka, K., Banchereau, J., Dendritic-cell-based therapeutic cancer vaccines (2013) Immunity, 39 (1), pp. 38-48
• Banchereau, J., Steinman, R.M., Dendritic cells and the control of immunity (1998) Nature, 392 (6673), pp. 245-252
• Mescher, M.F., Curtsinger, J.M., Agarwal, P., Casey, K.A., Gerner, M., Hammerbeck, C.D., Signals required for programming effector and memory development by CD8+ T cells (2006) Immunol Rev, 211, pp. 81-92
• Banerjee, A., Gordon, S.M., Intlekofer, A.M., Paley, M.A., Mooney, E.C., Lindsten, T., Cutting edge: the transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche (2010) J Immunol, 185 (9), pp. 4988-4992
• Woo, S.R., Corrales, L., Gajewski, T.F., Innate immune recognition of cancer (2015) Annu Rev Immunol, 33, pp. 445-474
• Anguille, S., Smits, E.L., Lion, E., van Tendeloo, V.F., Berneman, Z.N., Clinical use of dendritic cells for cancer therapy (2014) Lancet Oncol, 15 (7), pp. e257-e267
• Butterfield, L.H., Dendritic cells in cancer immunotherapy clinical trials: are we making progress? (2013) Front Immunol, 4, p. 454
• Galluzzi, L., Senovilla, L., Vacchelli, E., Eggermont, A., Fridman, W.H., Galon, J., Trial watch: dendritic cell-based interventions for cancer therapy (2012) Oncoimmunology, 1 (7), pp. 1111-1134
• Steinman, R.M., Cohn, Z.A., Identification of a novel cell type in peripheral lymphoid organs of mice I. Morphology, quantitation, tissue distribution (1973) J Exp Med, 137 (5), pp. 1142-1162
• Gross, L., Intradermal immunization of C3H mice against a sarcoma that originated in an animal of the same line (1943) Cancer Res, 3, pp. 326-333
• Klein, G., Klein, E., Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution (1977) Proc Natl Acad Sci U S A, 74 (5), pp. 2121-2125
• Cheon, D.J., Orsulic, S., Mouse models of cancer (2011) Annu Rev Pathol, 6, pp. 95-119
• Fidler, I.J., Tumor heterogeneity and the biology of cancer invasion and metastasis (1978) Cancer Res, 38 (9), pp. 2651-2660
• Nanni, P., Colombo, M.P., De Giovanni, C., Lollini, P.L., Nicoletti, G., Parmiani, G., Impaired H-2 expression in B16 melanoma variants (1983) J Immunogenet, 10 (5), pp. 361-370
• Overwijk, W.W., Restifo, N.P., B16 as a mouse model for human melanoma (2001) Curr Protoc Immunol, 20. , 20.1
• Davies, H., Bignell, G.R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Mutations of the BRAF gene in human cancer (2002) Nature, 417 (6892), pp. 949-954
• Melnikova, V.O., Bolshakov, S.V., Walker, C., Ananthaswamy, H.N., Genomic alterations in spontaneous and carcinogen-induced murine melanoma cell lines (2004) Oncogene, 23 (13), pp. 2347-2356
• Dankort, D., Curley, D.P., Cartlidge, R.A., Nelson, B., Karnezis, A.N., Damsky, W.E., Jr., Braf (V600E) cooperates with Pten loss to induce metastatic melanoma (2009) Nat Genet, 41 (5), pp. 544-552
• Jenkins, M.H., Steinberg, S.M., Alexander, M.P., Fisher, J.L., Ernstoff, M.S., Turk, M.J., Multiple murine BRaf (V600E) melanoma cell lines with sensitivity to PLX4032 (2014) Pigment Cell Melanoma Res, 27 (3), pp. 495-501
• Rappaport, A., Johnson, L., Genetically engineered knock-in and conditional knock-in mouse models of cancer (2014) Cold Spring Harb Protoc, 2014 (9), pp. 897-911
• Williams, S.A., Anderson, W.C., Santaguida, M.T., Dylla, S.J., Patient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century (2013) Lab Invest, 93 (9), pp. 970-982
• Shultz, L.D., Brehm, M.A., Garcia-Martinez, J.V., Greiner, D.L., Humanized mice for immune system investigation: progress, promise and challenges (2012) Nat Rev Immunol, 12 (11), pp. 786-798
• Sugamura, K., Asao, H., Kondo, M., Tanaka, N., Ishii, N., Ohbo, K., The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID (1996) Annu Rev Immunol, 14, pp. 179-205
• Cao, X., Shores, E.W., Hu-Li, J., Anver, M.R., Kelsall, B.L., Russell, S.M., Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain (1995) Immunity, 2 (3), pp. 223-238
• Shultz, L.D., Lyons, B.L., Burzenski, L.M., Gott, B., Chen, X., Chaleff, S., Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells (2005) J Immunol, 174 (10), pp. 6477-6489
• Shultz, L.D., Ishikawa, F., Greiner, D.L., Humanized mice in translational biomedical research (2007) Nat Rev Immunol, 7 (2), pp. 118-130
• Spranger, S., Frankenberger, B., Schendel, D.J., NOD/scid IL-2Rg (null) mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo (2012) J Transl Med, 10, p. 30
• Harui, A., Kiertscher, S.M., Roth, M.D., Reconstitution of huPBL-NSG mice with donor-matched dendritic cells enables antigen-specific T-cell activation (2011) J Neuroimmune Pharmacol, 6 (1), pp. 148-157
• Rongvaux, A., Willinger, T., Martinek, J., Strowig, T., Gearty, S.V., Teichmann, L.L., Development and function of human innate immune cells in a humanized mouse model (2014) Nat Biotechnol, 32 (4), pp. 364-372
• Drake, A.C., Chen, Q., Chen, J., Engineering humanized mice for improved hematopoietic reconstitution (2012) Cell Mol Immunol, 9 (3), pp. 215-224
• Morse, M.A., Zhou, L.J., Tedder, T.F., Lyerly, H.K., Smith, C., Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha for use in cancer immunotherapy (1997) Ann Surg, 226 (1), pp. 6-16
• Mitchell, D., Yong, M., Schroder, W., Black, M., Tirrell, M., Olive, C., Dual stimulation of MyD88-dependent toll-like receptors induces synergistically enhanced production of inflammatory cytokines in murine bone marrow-derived dendritic cells (2010) J Infect Dis, 202 (2), pp. 318-329
• Mac Keon, S., Gazzaniga, S., Mallerman, J., Bravo, A.I., Mordoh, J., Wainstok, R., Vaccination with dendritic cells charged with apoptotic/necrotic B16 melanoma induces the formation of subcutaneous lymphoid tissue (2010) Vaccine, 28 (51), pp. 8162-8168
• Ruiz, M.S., Mac Keon, S., Campisano, S., Bravo, A.I., Gazzaniga, S., Wainstok, R., CD207 (+) cells recruitment to the vaccination site and draining lymph nodes after the administration of DC-Apo/Nec vaccine in mice (2014) Vaccine, 32 (11), pp. 1229-1232
• Suzuki, H., Wang, B., Shivji, G.M., Toto, P., Amerio, P., Tomai, M.A., Imiquimod, a topical immune response modifier, induces migration of Langerhans cells (2000) J Invest Dermatol, 114 (1), pp. 135-141
• Nair, S., McLaughlin, C., Weizer, A., Su, Z., Boczkowski, D., Dannull, J., Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation (2003) J Immunol, 171 (11), pp. 6275-6282
• Wei, H., Wang, S., Zhang, D., Hou, S., Qian, W., Li, B., Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice (2009) Clin Cancer Res, 15 (14), pp. 4612-4621
• Wang, B., Zaidi, N., He, L.Z., Zhang, L., Kuroiwa, J.M., Keler, T., Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice (2012) Breast Cancer Res, 14 (2), p. R39
• Matheoud, D., Perie, L., Hoeffel, G., Vimeux, L., Parent, I., Maranon, C., Cross-presentation by dendritic cells from live cells induces protective immune responses in vivo (2010) Blood, 115 (22), pp. 4412-4420
• Matheoud, D., Baey, C., Vimeux, L., Tempez, A., Valente, M., Louche, P., Dendritic cells crosspresent antigens from live B16 cells more efficiently than from apoptotic cells and protect from melanoma in a therapeutic model (2011) PLoS One, 6 (4)
• Ma, F., Zhang, J., Zhang, C., The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice (2010) Cell Mol Immunol, 7 (5), pp. 381-388
• Flacher, V., Tripp, C.H., Mairhofer, D.G., Steinman, R.M., Stoitzner, P., Idoyaga, J., Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance (2014) EMBO Mol Med, 6 (9), pp. 1191-1204
• Keller, A.M., Xiao, Y., Peperzak, V., Naik, S.H., Borst, J., Costimulatory ligand CD70 allows induction of CD8+ T-cell immunity by immature dendritic cells in a vaccination setting (2009) Blood, 113 (21), pp. 5167-5175
• Sanchez, P.J., McWilliams, J.A., Haluszczak, C., Yagita, H., Kedl, R.M., Combined TLR/CD40 stimulation mediates potent cellular immunity by regulating dendritic cell expression of CD70 in vivo (2007) J Immunol, 178 (3), pp. 1564-1572
• McWilliams, J.A., Sanchez, P.J., Haluszczak, C., Gapin, L., Kedl, R.M., Multiple innate signaling pathways cooperate with CD40 to induce potent, CD70-dependent cellular immunity (2010) Vaccine, 28 (6), pp. 1468-1476
• Eberting, C.L., Shrayer, D.P., Butmarc, J., Falanga, V., Histologic progression of B16 F10 metastatic melanoma in C57BL/6 mice over a six week time period: distant metastases before local growth (2004) J Dermatol, 31 (4), pp. 299-304
• Bobek, V., Kolostova, K., Pinterova, D., Kacprzak, G., Adamiak, J., Kolodziej, J., A clinically relevant, syngeneic model of spontaneous, highly metastatic B16 mouse melanoma (2010) Anticancer Res, 30 (12), pp. 4799-4803
• Xia, S., Wei, J., Wang, J., Sun, H., Zheng, W., Li, Y., A requirement of dendritic cell-derived interleukin-27 for the tumor infiltration of regulatory T cells (2014) J Leukoc Biol, 95 (5), pp. 733-742
• Richmond, A., Su, Y., Mouse xenograft models vs GEM models for human cancer therapeutics (2008) Dis Model Mech, 1 (2-3), pp. 78-82
• Oflazoglu, E., Elliott, M., Takita, H., Ferrone, S., Henderson, R.A., Repasky, E.A., Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model (2007) J Transl Med, 5, p. 29
• Hylander, B.L., Punt, N., Tang, H., Hillman, J., Vaughan, M., Bshara, W., Origin of the vasculature supporting growth of primary patient tumor xenografts (2013) J Transl Med, 11, p. 110
• Eirew, P., Steif, A., Khattra, J., Ha, G., Yap, D., Farahani, H., Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution (2014) Nature, 518, pp. 422-426
• Pino, S., Brehm, M.A., Covassin-Barberis, L., King, M., Gott, B., Chase, T.H., Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease (2010) Methods Mol Biol, 602, pp. 105-117
• Mishra, S., Lavelle, B.J., Desrosiers, J., Ardito, M.T., Terry, F., Martin, W.D., Dendritic cell-mediated, DNA-based vaccination against hepatitis C induces the multi-epitope-specific response of humanized, HLA transgenic mice (2014) PLoS One, 9 (8)
• Meixlsperger, S., Leung, C.S., Ramer, P.C., Pack, M., Vanoaica, L.D., Breton, G., CD141+ dendritic cells produce prominent amounts of IFN-alpha after dsRNA recognition and can be targeted via DEC-205 in humanized mice (2013) Blood, 121 (25), pp. 5034-5044
• Malissen, B., Tamoutounour, S., Henri, S., The origins and functions of dendritic cells and macrophages in the skin (2014) Nat Rev Immunol, 14 (6), pp. 417-428
• Merad, M., Sathe, P., Helft, J., Miller, J., Mortha, A., The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting (2013) Annu Rev Immunol, 31, pp. 563-604
• Miller, J.C., Brown, B.D., Shay, T., Gautier, E.L., Jojic, V., Cohain, A., Deciphering the transcriptional network of the dendritic cell lineage (2012) Nat Immunol, 13 (9), pp. 888-899
• Belz, G.T., Nutt, S.L., Transcriptional programming of the dendritic cell network (2012) Nat Rev Immunol, 12 (2), pp. 101-113
• Stoecklinger, A., Eticha, T.D., Mesdaghi, M., Kissenpfennig, A., Malissen, B., Thalhamer, J., Langerin+ dermal dendritic cells are critical for CD8+ T cell activation and IgH gamma-1 class switching in response to gene gun vaccines (2011) J Immunol, 186 (3), pp. 1377-1383
• Dudziak, D., Kamphorst, A.O., Heidkamp, G.F., Buchholz, V.R., Trumpfheller, C., Yamazaki, S., Differential antigen processing by dendritic cell subsets in vivo (2007) Science, 315 (5808), pp. 107-111
• Xu, Y., Zhan, Y., Lew, A.M., Naik, S.H., Kershaw, M.H., Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking (2007) J Immunol, 179 (11), pp. 7577-7584
• Naik, S.H., Proietto, A.I., Wilson, N.S., Dakic, A., Schnorrer, P., Fuchsberger, M., Cutting edge: generation of splenic CD8+ and CD8-dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures (2005) J Immunol, 174 (11), pp. 6592-6597
• Dalod, M., Chelbi, R., Malissen, B., Lawrence, T., Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming (2014) EMBO J, 33 (10), pp. 1104-1116
• Schlitzer, A., McGovern, N., Teo, P., Zelante, T., Atarashi, K., Low, D., IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses (2013) Immunity, 38 (5), pp. 970-983
• Shortman, K., Heath, W.R., The CD8+ dendritic cell subset (2010) Immunol Rev, 234 (1), pp. 18-31
• Ginhoux, F., Liu, K., Helft, J., Bogunovic, M., Greter, M., Hashimoto, D., The origin and development of nonlymphoid tissue CD103+ DCs (2009) J Exp Med, 206 (13), pp. 3115-3130
• Iwasaki, A., Medzhitov, R., Toll-like receptor control of the adaptive immune responses (2004) Nat Immunol, 5 (10), pp. 987-995
• Mitsui, H., Watanabe, T., Saeki, H., Mori, K., Fujita, H., Tada, Y., Differential expression and function of toll-like receptors in Langerhans cells: comparison with splenic dendritic cells (2004) J Invest Dermatol, 122 (1), pp. 95-102
• Sancho, D., Mourao-Sa, D., Joffre, O.P., Schulz, O., Rogers, N.C., Pennington, D.J., Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin (2008) J Clin Invest, 118 (6), pp. 2098-2110
• Liu, K., Victora, G.D., Schwickert, T.A., Guermonprez, P., Meredith, M.M., Yao, K., In vivo analysis of dendritic cell development and homeostasis (2009) Science, 324 (5925), pp. 392-397
• Heng, T.S., Painter, M.W., The immunological genome project: networks of gene expression in immune cells (2008) Nat Immunol, 9 (10), pp. 1091-1094
• Drobits, B., Holcmann, M., Amberg, N., Swiecki, M., Grundtner, R., Hammer, M., Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells (2012) J Clin Invest, 122 (2), pp. 575-585
• Mouries, J., Moron, G., Schlecht, G., Escriou, N., Dadaglio, G., Leclerc, C., Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation (2008) Blood, 112 (9), pp. 3713-3722
• Guery, L., Dubrot, J., Lippens, C., Brighouse, D., Malinge, P., Irla, M., Ag-presenting CpG-activated pDCs prime Th17 cells that induce tumor regression (2014) Cancer Res, 74 (22), pp. 6430-6440
• Liu, C., Lou, Y., Lizee, G., Qin, H., Liu, S., Rabinovich, B., Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice (2008) J Clin Invest, 118 (3), pp. 1165-1175
• Treilleux, I., Blay, J.Y., Bendriss-Vermare, N., Ray-Coquard, I., Bachelot, T., Guastalla, J.P., Dendritic cell infiltration and prognosis of early stage breast cancer (2004) Clin Cancer Res, 10 (22), pp. 7466-7474
• Sisirak, V., Faget, J., Gobert, M., Goutagny, N., Vey, N., Treilleux, I., Impaired IFN-alpha production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression (2012) Cancer Res, 72 (20), pp. 5188-5197
• Wei, S., Kryczek, I., Zou, L., Daniel, B., Cheng, P., Mottram, P., Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma (2005) Cancer Res, 65 (12), pp. 5020-5026
• Watkins, S.K., Zhu, Z., Riboldi, E., Shafer-Weaver, K.A., Stagliano, K.E., Sklavos, M.M., FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer (2011) J Clin Invest, 121 (4), pp. 1361-1372
• Conrad, C., Gregorio, J., Wang, Y.H., Ito, T., Meller, S., Hanabuchi, S., Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3 (+) T-regulatory cells (2012) Cancer Res, 72 (20), pp. 5240-5249
• Sorrentino, R., Morello, S., Luciano, A., Crother, T.R., Maiolino, P., Bonavita, E., Plasmacytoid dendritic cells alter the antitumor activity of CpG-oligodeoxynucleotides in a mouse model of lung carcinoma (2010) J Immunol, 185 (8), pp. 4641-4650
• Le Mercier, I., Poujol, D., Sanlaville, A., Sisirak, V., Gobert, M., Durand, I., Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment (2013) Cancer Res, 73 (15), pp. 4629-4640
• Blasius, A.L., Giurisato, E., Cella, M., Schreiber, R.D., Shaw, A.S., Colonna, M., Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation (2006) J Immunol, 177 (5), pp. 3260-3265
• Sharma, M.D., Baban, B., Chandler, P., Hou, D.Y., Singh, N., Yagita, H., Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase (2007) J Clin Invest, 117 (9), pp. 2570-2582
• Johnson, B.A., III, Kahler, D.J., Baban, B., Chandler, P.R., Kang, B., Shimoda, M., B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase (2010) Proc Natl Acad Sci U S A, 107 (23), pp. 10644-10648
• Vinay, D.S., Kim, C.H., Chang, K.H., Kwon, B.S., PDCA expression by B lymphocytes reveals important functional attributes (2010) J Immunol, 184 (2), pp. 807-815
• Faget, J., Bendriss-Vermare, N., Gobert, M., Durand, I., Olive, D., Biota, C., ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells (2012) Cancer Res, 72 (23), pp. 6130-6141
• Borkowski, T.A., Letterio, J.J., Farr, A.G., Udey, M.C., A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells (1996) J Exp Med, 184 (6), pp. 2417-2422
• Nagao, K., Ginhoux, F., Leitner, W.W., Motegi, S., Bennett, C.L., Clausen, B.E., Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions (2009) Proc Natl Acad Sci U S A, 106 (9), pp. 3312-3317
• Poulin, L.F., Henri, S., de Bovis, B., Devilard, E., Kissenpfennig, A., Malissen, B., The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells (2007) J Exp Med, 204 (13), pp. 3119-3131
• Ginhoux, F., Collin, M.P., Bogunovic, M., Abel, M., Leboeuf, M., Helft, J., Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state (2007) J Exp Med, 204 (13), pp. 3133-3146
• Douillard, P., Stoitzner, P., Tripp, C.H., Clair-Moninot, V., Ait-Yahia, S., McLellan, A.D., Mouse lymphoid tissue contains distinct subsets of langerin/CD207 dendritic cells, only one of which represents epidermal-derived Langerhans cells (2005) J Invest Dermatol, 125 (5), pp. 983-994
• Flacher, V., Douillard, P., Ait-Yahia, S., Stoitzner, P., Clair-Moninot, V., Romani, N., Expression of langerin/CD207 reveals dendritic cell heterogeneity between inbred mouse strains (2008) Immunology, 123 (3), pp. 339-347
• Henri, S., Poulin, L.F., Tamoutounour, S., Ardouin, L., Guilliams, M., de Bovis, B., CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells (2010) J Exp Med, 207 (1), pp. 189-206
• Idoyaga, J., Cheong, C., Suda, K., Suda, N., Kim, J.Y., Lee, H., Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo (2008) J Immunol, 180 (6), pp. 3647-3650
• Stoitzner, P., Green, L.K., Jung, J.Y., Price, K.M., Tripp, C.H., Malissen, B., Tumor immunotherapy by epicutaneous immunization requires Langerhans cells (2008) J Immunol, 180 (3), pp. 1991-1998
• Flacher, V., Tripp, C.H., Stoitzner, P., Haid, B., Ebner, S., Del Frari, B., Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis (2010) J Invest Dermatol, 130 (3), pp. 755-762
• Hildner, K., Edelson, B.T., Purtha, W.E., Diamond, M., Matsushita, H., Kohyama, M., Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity (2008) Science, 322 (5904), pp. 1097-1100
• Fuertes, M.B., Kacha, A.K., Kline, J., Woo, S.R., Kranz, D.M., Murphy, K.M., Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells (2011) J Exp Med, 208 (10), pp. 2005-2016
• Diamond, M.S., Kinder, M., Matsushita, H., Mashayekhi, M., Dunn, G.P., Archambault, J.M., Type I interferon is selectively required by dendritic cells for immune rejection of tumors (2011) J Exp Med, 208 (10), pp. 1989-2003
• Azadmehr, A., Pourfathollah, A.A., Amirghofran, Z., Hassan, Z.M., Moazzeni, S.M., Enhancement of Th1 immune response by CD8alpha (+) dendritic cells loaded with heat shock proteins enriched tumor extract in tumor-bearing mice (2009) Cell Immunol, 260 (1), pp. 28-32
• Farrand, K.J., Dickgreber, N., Stoitzner, P., Ronchese, F., Petersen, T.R., Hermans, I.F., Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens (2009) J Immunol, 183 (12), pp. 7732-7742
• Macho-Fernandez, E., Cruz, L.J., Ghinnagow, R., Fontaine, J., Bialecki, E., Frisch, B., Targeted delivery of alpha-galactosylceramide to CD8alpha+ dendritic cells optimizes type I NKT cell-based antitumor responses (2014) J Immunol, 193 (2), pp. 961-969
• Arora, P., Baena, A., Yu, K.O., Saini, N.K., Kharkwal, S.S., Goldberg, M.F., A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigens (2014) Immunity, 40 (1), pp. 105-116
• Salio, M., Silk, J.D., Cerundolo, V., Recent advances in processing and presentation of CD1 bound lipid antigens (2010) Curr Opin Immunol, 22 (1), pp. 81-88
• Poulin, L.F., Reyal, Y., Uronen-Hansson, H., Schraml, B.U., Sancho, D., Murphy, K.M., DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues (2012) Blood, 119 (25), pp. 6052-6062
• Cerovic, V., Houston, S.A., Scott, C.L., Aumeunier, A., Yrlid, U., Mowat, A.M., Intestinal CD103 (-) dendritic cells migrate in lymph and prime effector T cells (2013) Mucosal Immunol, 6 (1), pp. 104-113
• Desch, A.N., Randolph, G.J., Murphy, K., Gautier, E.L., Kedl, R.M., Lahoud, M.H., CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen (2011) J Exp Med, 208 (9), pp. 1789-1797
• Decrausaz, L., Domingos-Pereira, S., Duc, M., Bobst, M., Romero, P., Schiller, J.T., Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus-associated genital tumors (2011) Int J Cancer, 129 (3), pp. 762-772
• Sandoval, F., Terme, M., Nizard, M., Badoual, C., Bureau, M.F., Freyburger, L., Mucosal imprinting of vaccine-induced CD8 (+) T cells is crucial to inhibit the growth of mucosal tumors (2013) Sci Transl Med, 5 (172)
• Kim-Schulze, S., Kim, H.S., Wainstein, A., Kim, D.W., Yang, W.C., Moroziewicz, D., Intrarectal vaccination with recombinant vaccinia virus expressing carcinoembronic antigen induces mucosal and systemic immunity and prevents progression of colorectal cancer (2008) J Immunol, 181 (11), pp. 8112-8119
• Broz, M.L., Binnewies, M., Boldajipour, B., Nelson, A.E., Pollack, J.L., Erle, D.J., Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity (2014) Cancer Cell, 26 (5), pp. 638-652
• Woo, S.R., Fuertes, M.B., Corrales, L., Spranger, S., Furdyna, M.J., Leung, M.Y., STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors (2014) Immunity, 41 (5), pp. 830-842
• Schulz, O., Jaensson, E., Persson, E.K., Liu, X., Worbs, T., Agace, W.W., Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions (2009) J Exp Med, 206 (13), pp. 3101-3114
• Lewis, K.L., Caton, M.L., Bogunovic, M., Greter, M., Grajkowska, L.T., Ng, D., Notch2 receptor signaling controls functional differentiation of dendritic cells in the spleen and intestine (2011) Immunity, 35 (5), pp. 780-791
• Guermonprez, P., Khelef, N., Blouin, E., Rieu, P., Ricciardi-Castagnoli, P., Guiso, N., The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha (M)beta (2) integrin (CD11b/CD18) (2001) J Exp Med, 193 (9), pp. 1035-1044
• Dadaglio, G., Fayolle, C., Zhang, X., Ryffel, B., Oberkampf, M., Felix, T., Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responses (2014) J Immunol, 193 (4), pp. 1787-1798
• Segura, E., Amigorena, S., Inflammatory dendritic cells in mice and humans (2013) Trends Immunol, 34 (9), pp. 440-445
• Dominguez, P.M., Ardavin, C., Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation (2010) Immunol Rev, 234 (1), pp. 90-104
• Nagai, Y., Garrett, K.P., Ohta, S., Bahrun, U., Kouro, T., Akira, S., Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment (2006) Immunity, 24 (6), pp. 801-812
• Segura, E., Amigorena, S., Identification of human inflammatory dendritic cells (2013) Oncoimmunology, 2 (5)
• Ma, Y., Adjemian, S., Mattarollo, S.R., Yamazaki, T., Aymeric, L., Yang, H., Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells (2013) Immunity, 38 (4), pp. 729-741
• Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor (1992) J Exp Med, 176 (6), pp. 1693-1702
• Labeur, M.S., Roters, B., Pers, B., Mehling, A., Luger, T.A., Schwarz, T., Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage (1999) J Immunol, 162 (1), pp. 168-175
• Goldszmid, R.S., Idoyaga, J., Bravo, A.I., Steinman, R., Mordoh, J., Wainstok, R., Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma (2003) J Immunol, 171 (11), pp. 5940-5947
• Campisano, S., Mac Keon, S., Gazzaniga, S., Ruiz, M.S., Traian, M.D., Mordoh, J., Anti-melanoma vaccinal capacity of CD11c-positive and-negative cell populations present in GM-CSF cultures derived from murine bone marrow precursors (2013) Vaccine, 31 (2), pp. 354-361
• Brasel, K., De Smedt, T., Smith, J.L., Maliszewski, C.R., Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures (2000) Blood, 96 (9), pp. 3029-3039
• Chen, W., Antonenko, S., Sederstrom, J.M., Liang, X., Chan, A.S., Kanzler, H., Thrombopoietin cooperates with FLT3-ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors (2004) Blood, 103 (7), pp. 2547-2553
• Poulin, L.F., Salio, M., Griessinger, E., Anjos-Afonso, F., Craciun, L., Chen, J.L., Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells (2010) J Exp Med, 207 (6), pp. 1261-1271
• Balan, S., Ollion, V., Colletti, N., Chelbi, R., Montanana-Sanchis, F., Liu, H., Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells (2014) J Immunol, 193 (4), pp. 1622-1635
• Lee, J., Breton, G., Oliveira, T.Y., Zhou, Y.J., Aljoufi, A., Puhr, S., Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow (2015) J Exp Med, 212 (3), pp. 385-399
• Petersen, T.R., Sika-Paotonu, D., Knight, D.A., Simkins, H.M., Hermans, I.F., Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT cells and CD8+ T cells to dendritic cell-based vaccines (2011) PLoS One, 6 (3)
• Allan, R.S., Waithman, J., Bedoui, S., Jones, C.M., Villadangos, J.A., Zhan, Y., Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming (2006) Immunity, 25 (1), pp. 153-162
• Kleindienst, P., Brocker, T., Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo (2003) J Immunol, 170 (6), pp. 2817-2823
• Yewdall, A.W., Drutman, S.B., Jinwala, F., Bahjat, K.S., Bhardwaj, N., CD8+ T cell priming by dendritic cell vaccines requires antigen transfer to endogenous antigen presenting cells (2010) PLoS One, 5 (6)
• Ali, O.A., Emerich, D., Dranoff, G., Mooney, D.J., In situ regulation of DC subsets and T cells mediates tumor regression in mice (2009) Sci Transl Med, 1 (8)
• Lou, Y., Liu, C., Kim, G.J., Liu, Y.J., Hwu, P., Wang, G., Plasmacytoid dendritic cells synergize with myeloid dendritic cells in the induction of antigen-specific antitumor immune responses (2007) J Immunol, 178 (3), pp. 1534-1541
• Dolan, B.P., Gibbs, K.D., Jr., Ostrand-Rosenberg, S., Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cells (2006) J Immunol, 177 (9), pp. 6018-6024
• Dolan, B.P., Gibbs, K.D., Jr., Ostrand-Rosenberg, S., Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines (2006) J Immunol, 176 (3), pp. 1447-1455
• Li, L., Kim, S., Herndon, J.M., Goedegebuure, P., Belt, B.A., Satpathy, A.T., Cross-dressed CD8alpha+/CD103+ dendritic cells prime CD8+ T cells following vaccination (2012) Proc Natl Acad Sci U S A, 109 (31), pp. 12716-12721
• Groettrup, M., Kirk, C.J., Basler, M., Proteasomes in immune cells: more than peptide producers? (2010) Nat Rev Immunol, 10 (1), pp. 73-78
• Guillaume, B., Stroobant, V., Bousquet-Dubouch, M.P., Colau, D., Chapiro, J., Parmentier, N., Analysis of the processing of seven human tumor antigens by intermediate proteasomes (2012) J Immunol, 189 (7), pp. 3538-3547
• Macagno, A., Gilliet, M., Sallusto, F., Lanzavecchia, A., Nestle, F.O., Groettrup, M., Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation (1999) Eur J Immunol, 29 (12), pp. 4037-4042
• Dannull, J., Haley, N.R., Archer, G., Nair, S., Boczkowski, D., Harper, M., Melanoma immunotherapy using mature DCs expressing the constitutive proteasome (2013) J Clin Invest, 123 (7), pp. 3135-3145
• Butterfield, L.H., Palucka, A.K., Britten, C.M., Dhodapkar, M.V., Hakansson, L., Janetzki, S., Recommendations from the iSBTc-SITC/FDA/NCI workshop on immunotherapy biomarkers (2011) Clin Cancer Res, 17 (10), pp. 3064-3076
• Castle, J.C., Kreiter, S., Diekmann, J., Lower, M., van de Roemer, N., de Graaf, J., Exploiting the mutanome for tumor vaccination (2012) Cancer Res, 72 (5), pp. 1081-1091
• Casey, D.G., Lysaght, J., James, T., Bateman, A., Melcher, A.A., Todryk, S.M., Heat shock protein derived from a non-autologous tumour can be used as an anti-tumour vaccine (2003) Immunology, 110 (1), pp. 105-111
• Li, B., Simmons, A., Du, T., Lin, C., Moskalenko, M., Gonzalez-Edick, M., Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies (2009) Clin Immunol, 133 (2), pp. 184-197
• Ning, N., Pan, Q., Zheng, F., Teitz-Tennenbaum, S., Egenti, M., Yet, J., Cancer stem cell vaccination confers significant antitumor immunity (2012) Cancer Res, 72 (7), pp. 1853-1864
• Teitz-Tennenbaum, S., Wicha, M.S., Chang, A.E., Li, Q., Targeting cancer stem cells via dendritic-cell vaccination (2012) Oncoimmunology, 1 (8), pp. 1401-1403
• Sauter, B., Albert, M.L., Francisco, L., Larsson, M., Somersan, S., Bhardwaj, N., Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells (2000) J Exp Med, 191 (3), pp. 423-434
• Fry, T.J., Shand, J.L., Milliron, M., Tasian, S.K., Mackall, C.L., Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches (2009) Cancer Immunol Immunother, 58 (8), pp. 1257-1264
• Deng, L., Liang, H., Xu, M., Yang, X., Burnette, B., Arina, A., STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors (2014) Immunity, 41 (5), pp. 843-852
• Schnurr, M., Scholz, C., Rothenfusser, S., Galambos, P., Dauer, M., Robe, J., Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells (2002) Cancer Res, 62 (8), pp. 2347-2352
• Inzkirweli, N., Guckel, B., Sohn, C., Wallwiener, D., Bastert, G., Lindner, M., Antigen loading of dendritic cells with apoptotic tumor cell-preparations is superior to that using necrotic cells or tumor lysates (2007) Anticancer Res, 27 (4 B), pp. 2121-2129
• Yoon, T.J., Kim, J.Y., Kim, H., Hong, C., Lee, H., Lee, C.K., Anti-tumor immunostimulatory effect of heat-killed tumor cells (2008) Exp Mol Med, 40 (1), pp. 130-144
• Kawahara, M., Takaku, H., Intradermal immunization with combined baculovirus and tumor cell lysate induces effective antitumor immunity in mice (2013) Int J Oncol, 43 (6), pp. 2023-2030
• Kroemer, G., Galluzzi, L., Kepp, O., Zitvogel, L., Immunogenic cell death in cancer therapy (2013) Annu Rev Immunol, 31, pp. 51-72
• Krysko, D.V., Garg, A.D., Kaczmarek, A., Krysko, O., Agostinis, P., Vandenabeele, P., Immunogenic cell death and DAMPs in cancer therapy (2012) Nat Rev Cancer, 12 (12), pp. 860-875
• Todryk, S., Melcher, A.A., Hardwick, N., Linardakis, E., Bateman, A., Colombo, M.P., Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake (1999) J Immunol, 163 (3), pp. 1398-1408
• Calderwood, S.K., Theriault, J.R., Gong, J., How is the immune response affected by hyperthermia and heat shock proteins? (2005) Int J Hyperthermia, 21 (8), pp. 713-716
• Asea, A., Kraeft, S.K., Kurt-Jones, E.A., Stevenson, M.A., Chen, L.B., Finberg, R.W., HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine (2000) Nat Med, 6 (4), pp. 435-442
• Wang, X.Y., Yi, H., Yu, X., Zuo, D., Subjeck, J.R., Enhancing antigen cross-presentation and T-cell priming by complexing protein antigen to recombinant large heat-shock protein (2011) Methods Mol Biol, 787, pp. 277-287
• Jiang, J., Xie, D., Zhang, W., Xiao, G., Wen, J., Fusion of Hsp70 to Mage-a1 enhances the potency of vaccine-specific immune responses (2013) J Transl Med, 11, p. 300
• McNulty, S., Colaco, C.A., Blandford, L.E., Bailey, C.R., Baschieri, S., Todryk, S., Heat-shock proteins as dendritic cell-targeting vaccines-getting warmer (2013) Immunology, 139 (4), pp. 407-415
• Enomoto, Y., Bharti, A., Khaleque, A.A., Song, B., Liu, C., Apostolopoulos, V., Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells (2006) J Immunol, 177 (9), pp. 5946-5955
• Harshyne, L.A., Watkins, S.C., Gambotto, A., Barratt-Boyes, S.M., Dendritic cells acquire antigens from live cells for cross-presentation to CTL (2001) J Immunol, 166 (6), pp. 3717-3723
• Toes, R.E., Blom, R.J., van der Voort, E., Offringa, R., Melief, C.J., Kast, W.M., Protective antitumor immunity induced by immunization with completely allogeneic tumor cells (1996) Cancer Res, 56 (16), pp. 3782-3787
• Yasuda, T., Kamigaki, T., Kawasaki, K., Nakamura, T., Yamamoto, M., Kanemitsu, K., Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma (2007) Cancer Immunol Immunother, 56 (7), pp. 1025-1036
• Merrick, A., Diaz, R.M., O'Donnell, D., Selby, P., Vile, R., Melcher, A., Autologous versus allogeneic peptide-pulsed dendritic cells for anti-tumour vaccination: expression of allogeneic MHC supports activation of antigen specific T cells, but impairs early naive cytotoxic priming and anti-tumour therapy (2008) Cancer Immunol Immunother, 57 (6), pp. 897-906
• Suzuki, T., Fukuhara, T., Tanaka, M., Nakamura, A., Akiyama, K., Sakakibara, T., Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells (2005) Clin Cancer Res, 11 (1), pp. 58-66
• Herzog, G.I., Solgi, G., Wiegmann, D.S., Nienhaus, C., Schrezenmeier, H., Yildiz, T., Quality of tumor lysates used for pulsing dendritic cells is influenced by the method used to harvest adherent tumor cells (2011) BMC Res Notes, 4, p. 153
• Olin, M.R., Andersen, B.M., Zellmer, D.M., Grogan, P.T., Popescu, F.E., Xiong, Z., Superior efficacy of tumor cell vaccines grown in physiologic oxygen (2010) Clin Cancer Res, 16 (19), pp. 4800-4808
• Koido, S., Homma, S., Okamoto, M., Namiki, Y., Takakura, K., Uchiyama, K., Strategies to improve the immunogenicity of anticancer vaccines based on dendritic cell/malignant cell fusions (2013) Oncoimmunology, 2 (9)
• Tanaka, Y., Koido, S., Ohana, M., Liu, C., Gong, J., Induction of impaired antitumor immunity by fusion of MHC class II-deficient dendritic cells with tumor cells (2005) J Immunol, 174 (3), pp. 1274-1280
• Ishida, A., Tanaka, H., Hiura, T., Miura, S., Watanabe, S., Matsuyama, K., Generation of anti-tumour effector T cells from naive T cells by stimulation with dendritic/tumour fusion cells (2007) Scand J Immunol, 66 (5), pp. 546-554
• Tamai, H., Watanabe, S., Zheng, R., Deguchi, K., Cohen, P.A., Koski, G.K., Effective treatment of spontaneous metastases derived from a poorly immunogenic murine mammary carcinoma by combined dendritic-tumor hybrid vaccination and adoptive transfer of sensitized T cells (2008) Clin Immunol, 127 (1), pp. 66-77
• Guo, G.H., Chen, S.Z., Yu, J., Zhang, J., Luo, L.L., Xie, L.H., In vivo anti-tumor effect of hybrid vaccine of dendritic cells and esophageal carcinoma cells on esophageal carcinoma cell line 109 in mice with severe combined immune deficiency (2008) World J Gastroenterol, 14 (8), pp. 1167-1174
• Yamamoto, M., Kamigaki, T., Yamashita, K., Hori, Y., Hasegawa, H., Kuroda, D., Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer (2009) Oncol Rep, 22 (2), pp. 337-343
• Tan, C., Dannull, J., Nair, S.K., Ding, E., Tyler, D.S., Pruitt, S.K., Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccination (2013) J Surg Res, 185 (2), pp. 904-911
• Chen, X., Liu, Z., Huang, Y., Li, R., Zhang, H., Dong, S., Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma (2014) Autoimmunity, 47 (1), pp. 46-56
• Tanaka, Y., Koido, S., Chen, D., Gendler, S.J., Kufe, D., Gong, J., Vaccination with allogeneic dendritic cells fused to carcinoma cells induces antitumor immunity in MUC1 transgenic mice (2001) Clin Immunol, 101 (2), pp. 192-200
• Chen, D., Xia, J., Tanaka, Y., Chen, H., Koido, S., Wernet, O., Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells (2003) Immunology, 109 (2), pp. 300-307
• Koido, S., Hara, E., Homma, S., Torii, A., Mitsunaga, M., Yanagisawa, S., Streptococcal preparation OK-432 promotes fusion efficiency and enhances induction of antigen-specific CTL by fusions of dendritic cells and colorectal cancer cells (2007) J Immunol, 178 (1), pp. 613-622
• Caminschi, I., Shortman, K., Boosting antibody responses by targeting antigens to dendritic cells (2012) Trends Immunol, 33 (2), pp. 71-77
• Hartung, E., Becker, M., Bachem, A., Reeg, N., Jakel, A., Hutloff, A., Induction of potent CD8 T cell cytotoxicity by specific targeting of antigen to cross-presenting dendritic cells in vivo via murine or human XCR1 (2015) J Immunol, 194 (3), pp. 1069-1079
• Dhodapkar, M.V., Sznol, M., Zhao, B., Wang, D., Carvajal, R.D., Keohan, M.L., Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205 (2014) Sci Transl Med, 6 (232)
• Mellman, I., Steinman, R.M., Dendritic cells: specialized and regulated antigen processing machines (2001) Cell, 106 (3), pp. 255-258
• Van Brussel, I., Berneman, Z.N., Cools, N., Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system (2012) Mediators Inflamm, 2012
• Taraban, V.Y., Rowley, T.F., Al-Shamkhani, A., Cutting edge: a critical role for CD70 in CD8 T cell priming by CD40-licensed APCs (2004) J Immunol, 173 (11), pp. 6542-6546
• Ohl, L., Mohaupt, M., Czeloth, N., Hintzen, G., Kiafard, Z., Zwirner, J., CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions (2004) Immunity, 21 (2), pp. 279-288
• Jonuleit, H., Kuhn, U., Muller, G., Steinbrink, K., Paragnik, L., Schmitt, E., Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions (1997) Eur J Immunol, 27 (12), pp. 3135-3142
• Zobywalski, A., Javorovic, M., Frankenberger, B., Pohla, H., Kremmer, E., Bigalke, I., Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70 (2007) J Transl Med, 5, p. 18
• Curtsinger, J.M., Johnson, C.M., Mescher, M.F., CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine (2003) J Immunol, 171 (10), pp. 5165-5171
• Agarwal, P., Raghavan, A., Nandiwada, S.L., Curtsinger, J.M., Bohjanen, P.R., Mueller, D.L., Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory (2009) J Immunol, 183 (3), pp. 1695-1704
• Zapala, L., Wolny, R., Wachowska, M., Jakobisiak, M., Lasek, W., Synergistic antitumor effect of JAWSII dendritic cells and interleukin 12 in a melanoma mouse model (2013) Oncol Rep, 29 (3), pp. 1208-1214
• Leonard, J.P., Sherman, M.L., Fisher, G.L., Buchanan, L.J., Larsen, G., Atkins, M.B., Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production (1997) Blood, 90 (7), pp. 2541-2548
• Carreno, B.M., Becker-Hapak, M., Huang, A., Chan, M., Alyasiry, A., Lie, W.R., IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity (2013) J Clin Invest, 123 (8), pp. 3383-3394
• Peterson, A.C., Harlin, H., Gajewski, T.F., Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma (2003) J Clin Oncol, 21 (12), pp. 2342-2348
• Hamid, O., Solomon, J.C., Scotland, R., Garcia, M., Sian, S., Ye, W., Alum with interleukin-12 augments immunity to a melanoma peptide vaccine: correlation with time to relapse in patients with resected high-risk disease (2007) Clin Cancer Res, 13 (1), pp. 215-222
• Inaba, K., Steinman, R.M., Pack, M.W., Aya, H., Inaba, M., Sudo, T., Identification of proliferating dendritic cell precursors in mouse blood (1992) J Exp Med, 175 (5), pp. 1157-1167
• Dranoff, G., GM-CSF-secreting melanoma vaccines (2003) Oncogene, 22 (20), pp. 3188-3192
• Ojima, T., Iwahashi, M., Nakamura, M., Matsuda, K., Naka, T., Nakamori, M., The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen (2006) Int J Oncol, 28 (4), pp. 947-953
• Narusawa, M., Inoue, H., Sakamoto, C., Matsumura, Y., Takahashi, A., Inoue, T., TLR7 ligand augments GM-CSF-initiated antitumor immunity through activation of plasmacytoid dendritic cells (2014) Cancer Immunol Res, 2 (6), pp. 568-580
• Mach, N., Gillessen, S., Wilson, S.B., Sheehan, C., Mihm, M., Dranoff, G., Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand (2000) Cancer Res, 60 (12), pp. 3239-3246
• Kawai, T., Akira, S., Signaling to NF-kappaB by toll-like receptors (2007) Trends Mol Med, 13 (11), pp. 460-469
• Prchal, M., Pilz, A., Simma, O., Lingnau, K., von Gabain, A., Strobl, B., Type I interferons as mediators of immune adjuvants for T-and B cell-dependent acquired immunity (2009) Vaccine, 27, pp. G17-G20
• Datta, S.K., Redecke, V., Prilliman, K.R., Takabayashi, K., Corr, M., Tallant, T., A subset of toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells (2003) J Immunol, 170 (8), pp. 4102-4110
• Warger, T., Osterloh, P., Rechtsteiner, G., Fassbender, M., Heib, V., Schmid, B., Synergistic activation of dendritic cells by combined toll-like receptor ligation induces superior CTL responses in vivo (2006) Blood, 108 (2), pp. 544-550
• Sidky, Y.A., Borden, E.C., Weeks, C.E., Reiter, M.J., Hatcher, J.F., Bryan, G.T., Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine (1992) Cancer Res, 52 (13), pp. 3528-3533
• Lee, J.R., Shin, J.H., Park, J.H., Song, S.U., Choi, G.S., Combined treatment with intratumoral injection of dendritic cells and topical application of imiquimod for murine melanoma (2007) Clin Exp Dermatol, 32 (5), pp. 541-549
• Wilgenhof, S., Van Nuffel, A.M., Corthals, J., Heirman, C., Tuyaerts, S., Benteyn, D., Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma (2011) J Immunother, 34 (5), pp. 448-456
• Fujii, S., Liu, K., Smith, C., Bonito, A.J., Steinman, R.M., The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation (2004) J Exp Med, 199 (12), pp. 1607-1618
• Taraban, V.Y., Martin, S., Attfield, K.E., Glennie, M.J., Elliott, T., Elewaut, D., Invariant NKT cells promote CD8+ cytotoxic T cell responses by inducing CD70 expression on dendritic cells (2008) J Immunol, 180 (7), pp. 4615-4620
• Dang, Y., Wagner, W.M., Gad, E., Rastetter, L., Berger, C.M., Holt, G.E., Dendritic cell-activating vaccine adjuvants differ in the ability to elicit antitumor immunity due to an adjuvant-specific induction of immunosuppressive cells (2012) Clin Cancer Res, 18 (11), pp. 3122-3131
• Prins, R.M., Soto, H., Konkankit, V., Odesa, S.K., Eskin, A., Yong, W.H., Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy (2011) Clin Cancer Res, 17 (6), pp. 1603-1615

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------